article Open AccessTop 1% cited

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

BMJ · 2020 · Vol. 368 · pp. m606–m606

Xiaowei Xu✉(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)Xiaoxin Wu(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)Xiangao Jiang(Wenzhou Central Hospital)Kaijin Xu(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)Lingjun Ying(Wenzhou Medical University)Chunlian Ma(The First People's Hospital of Wenling)Shibo Li(Wenzhou Medical University)Huaying Wang(Ningbo University)Sheng Zhang(Wenzhou Medical University)Hainv Gao(Zhejiang Shuren University)Jifang Sheng(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)Hongliu Cai(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)Yunqing Qiu(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)Lanjuan Li(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)

View via DOI Full-text PDF

Abstract

As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild.

COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research Long-Term Effects of COVID-19MedicineInterquartile rangemyalgiaRetrospective cohort studyIntensive care unitPediatricsCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseInfectious disease (medical specialty)

MeSH terms

AdolescentAdultChildChinaCoughFemaleFeverHumansMaleMiddle AgedPrognosisRetrospective StudiesRadiography, ThoracicTomography, X-Ray ComputedCoronavirus Infections

Citations

2,176

FWCI

53.54

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Evaluation of hematological parameters in covid-19 patients in district Hapur